Global Anthrax Vaccines Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Anthrax Vaccines market size is predicted to grow from US$ 741 million in 2025 to US$ 1168 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
LP Information, Inc. (LPI) ' newest research report, the “Anthrax Vaccines Industry Forecast” looks at past sales and reviews total world Anthrax Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Anthrax Vaccines sales for 2025 through 2031. With Anthrax Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anthrax Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Anthrax Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anthrax Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anthrax Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anthrax Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anthrax Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anthrax Vaccines market?
What factors are driving Anthrax Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anthrax Vaccines market opportunities vary by end market size?
How does Anthrax Vaccines break out by Type, by Application?
The global Anthrax Vaccines market size is predicted to grow from US$ 741 million in 2025 to US$ 1168 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
LP Information, Inc. (LPI) ' newest research report, the “Anthrax Vaccines Industry Forecast” looks at past sales and reviews total world Anthrax Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Anthrax Vaccines sales for 2025 through 2031. With Anthrax Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anthrax Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Anthrax Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anthrax Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anthrax Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anthrax Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anthrax Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Live Vaccines
- Cell free PA Vaccines
- Human Use
- Animal Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Emergent BioSolutions
- Merial
- Merck
- Zoetis
- Bayer Sanidad Animal
- Colorado Serum
- PharmAthene
- Tiankang
- Biogйnesis-Bago
- CAVAC
- Rosenbusch
- Agrovet
- Vecol
- CVCRI
- IVPM
- Prondil
- CDV
- Indian Immunologicals
- Botswana Vaccine Institute
- Ceva Santй Animale
- Intervac
- JOVAC
What is the 10-year outlook for the global Anthrax Vaccines market?
What factors are driving Anthrax Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anthrax Vaccines market opportunities vary by end market size?
How does Anthrax Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anthrax Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anthrax Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anthrax Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Anthrax Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell free PA Vaccines
2.3 Anthrax Vaccines Sales by Type
2.3.1 Global Anthrax Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Anthrax Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anthrax Vaccines Sale Price by Type (2020-2025)
2.4 Anthrax Vaccines Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Anthrax Vaccines Sales by Application
2.5.1 Global Anthrax Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Anthrax Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anthrax Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anthrax Vaccines Breakdown Data by Company
3.1.1 Global Anthrax Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Anthrax Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Anthrax Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Anthrax Vaccines Revenue by Company (2020-2025)
3.2.2 Global Anthrax Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Anthrax Vaccines Sale Price by Company
3.4 Key Manufacturers Anthrax Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anthrax Vaccines Product Location Distribution
3.4.2 Players Anthrax Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTHRAX VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Anthrax Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Anthrax Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anthrax Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anthrax Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Anthrax Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anthrax Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anthrax Vaccines Sales Growth
4.4 APAC Anthrax Vaccines Sales Growth
4.5 Europe Anthrax Vaccines Sales Growth
4.6 Middle East & Africa Anthrax Vaccines Sales Growth
5 AMERICAS
5.1 Americas Anthrax Vaccines Sales by Country
5.1.1 Americas Anthrax Vaccines Sales by Country (2020-2025)
5.1.2 Americas Anthrax Vaccines Revenue by Country (2020-2025)
5.2 Americas Anthrax Vaccines Sales by Type (2020-2025)
5.3 Americas Anthrax Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anthrax Vaccines Sales by Region
6.1.1 APAC Anthrax Vaccines Sales by Region (2020-2025)
6.1.2 APAC Anthrax Vaccines Revenue by Region (2020-2025)
6.2 APAC Anthrax Vaccines Sales by Type (2020-2025)
6.3 APAC Anthrax Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anthrax Vaccines by Country
7.1.1 Europe Anthrax Vaccines Sales by Country (2020-2025)
7.1.2 Europe Anthrax Vaccines Revenue by Country (2020-2025)
7.2 Europe Anthrax Vaccines Sales by Type (2020-2025)
7.3 Europe Anthrax Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anthrax Vaccines by Country
8.1.1 Middle East & Africa Anthrax Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anthrax Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Anthrax Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Anthrax Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anthrax Vaccines
10.3 Manufacturing Process Analysis of Anthrax Vaccines
10.4 Industry Chain Structure of Anthrax Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anthrax Vaccines Distributors
11.3 Anthrax Vaccines Customer
12 WORLD FORECAST REVIEW FOR ANTHRAX VACCINES BY GEOGRAPHIC REGION
12.1 Global Anthrax Vaccines Market Size Forecast by Region
12.1.1 Global Anthrax Vaccines Forecast by Region (2026-2031)
12.1.2 Global Anthrax Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anthrax Vaccines Forecast by Type (2026-2031)
12.7 Global Anthrax Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Emergent BioSolutions
13.1.1 Emergent BioSolutions Company Information
13.1.2 Emergent BioSolutions Anthrax Vaccines Product Portfolios and Specifications
13.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Emergent BioSolutions Main Business Overview
13.1.5 Emergent BioSolutions Latest Developments
13.2 Merial
13.2.1 Merial Company Information
13.2.2 Merial Anthrax Vaccines Product Portfolios and Specifications
13.2.3 Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merial Main Business Overview
13.2.5 Merial Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Anthrax Vaccines Product Portfolios and Specifications
13.3.3 Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Zoetis
13.4.1 Zoetis Company Information
13.4.2 Zoetis Anthrax Vaccines Product Portfolios and Specifications
13.4.3 Zoetis Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Zoetis Main Business Overview
13.4.5 Zoetis Latest Developments
13.5 Bayer Sanidad Animal
13.5.1 Bayer Sanidad Animal Company Information
13.5.2 Bayer Sanidad Animal Anthrax Vaccines Product Portfolios and Specifications
13.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bayer Sanidad Animal Main Business Overview
13.5.5 Bayer Sanidad Animal Latest Developments
13.6 Colorado Serum
13.6.1 Colorado Serum Company Information
13.6.2 Colorado Serum Anthrax Vaccines Product Portfolios and Specifications
13.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Colorado Serum Main Business Overview
13.6.5 Colorado Serum Latest Developments
13.7 PharmAthene
13.7.1 PharmAthene Company Information
13.7.2 PharmAthene Anthrax Vaccines Product Portfolios and Specifications
13.7.3 PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 PharmAthene Main Business Overview
13.7.5 PharmAthene Latest Developments
13.8 Tiankang
13.8.1 Tiankang Company Information
13.8.2 Tiankang Anthrax Vaccines Product Portfolios and Specifications
13.8.3 Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Tiankang Main Business Overview
13.8.5 Tiankang Latest Developments
13.9 Biogйnesis-Bago
13.9.1 Biogйnesis-Bago Company Information
13.9.2 Biogйnesis-Bago Anthrax Vaccines Product Portfolios and Specifications
13.9.3 Biogйnesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Biogйnesis-Bago Main Business Overview
13.9.5 Biogйnesis-Bago Latest Developments
13.10 CAVAC
13.10.1 CAVAC Company Information
13.10.2 CAVAC Anthrax Vaccines Product Portfolios and Specifications
13.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 CAVAC Main Business Overview
13.10.5 CAVAC Latest Developments
13.11 Rosenbusch
13.11.1 Rosenbusch Company Information
13.11.2 Rosenbusch Anthrax Vaccines Product Portfolios and Specifications
13.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Rosenbusch Main Business Overview
13.11.5 Rosenbusch Latest Developments
13.12 Agrovet
13.12.1 Agrovet Company Information
13.12.2 Agrovet Anthrax Vaccines Product Portfolios and Specifications
13.12.3 Agrovet Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Agrovet Main Business Overview
13.12.5 Agrovet Latest Developments
13.13 Vecol
13.13.1 Vecol Company Information
13.13.2 Vecol Anthrax Vaccines Product Portfolios and Specifications
13.13.3 Vecol Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Vecol Main Business Overview
13.13.5 Vecol Latest Developments
13.14 CVCRI
13.14.1 CVCRI Company Information
13.14.2 CVCRI Anthrax Vaccines Product Portfolios and Specifications
13.14.3 CVCRI Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 CVCRI Main Business Overview
13.14.5 CVCRI Latest Developments
13.15 IVPM
13.15.1 IVPM Company Information
13.15.2 IVPM Anthrax Vaccines Product Portfolios and Specifications
13.15.3 IVPM Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 IVPM Main Business Overview
13.15.5 IVPM Latest Developments
13.16 Prondil
13.16.1 Prondil Company Information
13.16.2 Prondil Anthrax Vaccines Product Portfolios and Specifications
13.16.3 Prondil Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Prondil Main Business Overview
13.16.5 Prondil Latest Developments
13.17 CDV
13.17.1 CDV Company Information
13.17.2 CDV Anthrax Vaccines Product Portfolios and Specifications
13.17.3 CDV Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 CDV Main Business Overview
13.17.5 CDV Latest Developments
13.18 Indian Immunologicals
13.18.1 Indian Immunologicals Company Information
13.18.2 Indian Immunologicals Anthrax Vaccines Product Portfolios and Specifications
13.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Indian Immunologicals Main Business Overview
13.18.5 Indian Immunologicals Latest Developments
13.19 Botswana Vaccine Institute
13.19.1 Botswana Vaccine Institute Company Information
13.19.2 Botswana Vaccine Institute Anthrax Vaccines Product Portfolios and Specifications
13.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Botswana Vaccine Institute Main Business Overview
13.19.5 Botswana Vaccine Institute Latest Developments
13.20 Ceva Santй Animale
13.20.1 Ceva Santй Animale Company Information
13.20.2 Ceva Santй Animale Anthrax Vaccines Product Portfolios and Specifications
13.20.3 Ceva Santй Animale Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Ceva Santй Animale Main Business Overview
13.20.5 Ceva Santй Animale Latest Developments
13.21 Intervac
13.21.1 Intervac Company Information
13.21.2 Intervac Anthrax Vaccines Product Portfolios and Specifications
13.21.3 Intervac Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Intervac Main Business Overview
13.21.5 Intervac Latest Developments
13.22 JOVAC
13.22.1 JOVAC Company Information
13.22.2 JOVAC Anthrax Vaccines Product Portfolios and Specifications
13.22.3 JOVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 JOVAC Main Business Overview
13.22.5 JOVAC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Anthrax Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anthrax Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Cell free PA Vaccines
Table 5. Global Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 6. Global Anthrax Vaccines Sales Market Share byType (2020-2025)
Table 7. Global Anthrax Vaccines Revenue byType (2020-2025) & ($ million)
Table 8. Global Anthrax Vaccines Revenue Market Share byType (2020-2025)
Table 9. Global Anthrax Vaccines Sale Price byType (2020-2025) & (USD/Dose)
Table 10. Global Anthrax Vaccines Sale by Application (2020-2025) & (M Doses)
Table 11. Global Anthrax Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Anthrax Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Anthrax Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Anthrax Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Anthrax Vaccines Sales by Company (2020-2025) & (M Doses)
Table 16. Global Anthrax Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Anthrax Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Anthrax Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Anthrax Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Anthrax Vaccines Producing Area Distribution and Sales Area
Table 21. Players Anthrax Vaccines Products Offered
Table 22. Anthrax Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Anthrax Vaccines Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Anthrax Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Anthrax Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Anthrax Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Anthrax Vaccines Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Anthrax Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Anthrax Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Anthrax Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Anthrax Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Anthrax Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 37. Americas Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Anthrax Vaccines Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Anthrax Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Anthrax Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 42. APAC Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Anthrax Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 46. Europe Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Anthrax Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Anthrax Vaccines
Table 52. Key Market Challenges & Risks of Anthrax Vaccines
Table 53. Key IndustryTrends of Anthrax Vaccines
Table 54. Anthrax Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Anthrax Vaccines Distributors List
Table 57. Anthrax Vaccines Customer List
Table 58. Global Anthrax Vaccines SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global Anthrax Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Anthrax Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas Anthrax Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Anthrax Vaccines SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC Anthrax Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Anthrax Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe Anthrax Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Anthrax Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Anthrax Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Anthrax Vaccines SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global Anthrax Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Anthrax Vaccines SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global Anthrax Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Emergent BioSolutions Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Emergent BioSolutions Anthrax Vaccines Product Portfolios and Specifications
Table 74. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Emergent BioSolutions Main Business
Table 76. Emergent BioSolutions Latest Developments
Table 77. Merial Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Merial Anthrax Vaccines Product Portfolios and Specifications
Table 79. Merial Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Merial Main Business
Table 81. Merial Latest Developments
Table 82. Merck Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Anthrax Vaccines Product Portfolios and Specifications
Table 84. Merck Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Zoetis Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Zoetis Anthrax Vaccines Product Portfolios and Specifications
Table 89. Zoetis Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Zoetis Main Business
Table 91. Zoetis Latest Developments
Table 92. Bayer Sanidad Animal Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer Sanidad Animal Anthrax Vaccines Product Portfolios and Specifications
Table 94. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Bayer Sanidad Animal Main Business
Table 96. Bayer Sanidad Animal Latest Developments
Table 97. Colorado Serum Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Colorado Serum Anthrax Vaccines Product Portfolios and Specifications
Table 99. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Colorado Serum Main Business
Table 101. Colorado Serum Latest Developments
Table 102. PharmAthene Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. PharmAthene Anthrax Vaccines Product Portfolios and Specifications
Table 104. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. PharmAthene Main Business
Table 106. PharmAthene Latest Developments
Table 107.Tiankang Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108.Tiankang Anthrax Vaccines Product Portfolios and Specifications
Table 109.Tiankang Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110.Tiankang Main Business
Table 111.Tiankang Latest Developments
Table 112. Biogйnesis-Bago Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Biogйnesis-Bago Anthrax Vaccines Product Portfolios and Specifications
Table 114. Biogйnesis-Bago Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Biogйnesis-Bago Main Business
Table 116. Biogйnesis-Bago Latest Developments
Table 117. CAVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. CAVAC Anthrax Vaccines Product Portfolios and Specifications
Table 119. CAVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. CAVAC Main Business
Table 121. CAVAC Latest Developments
Table 122. Rosenbusch Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Rosenbusch Anthrax Vaccines Product Portfolios and Specifications
Table 124. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Rosenbusch Main Business
Table 126. Rosenbusch Latest Developments
Table 127. Agrovet Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Agrovet Anthrax Vaccines Product Portfolios and Specifications
Table 129. Agrovet Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 130. Agrovet Main Business
Table 131. Agrovet Latest Developments
Table 132. Vecol Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Vecol Anthrax Vaccines Product Portfolios and Specifications
Table 134. Vecol Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 135. Vecol Main Business
Table 136. Vecol Latest Developments
Table 137. CVCRI Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. CVCRI Anthrax Vaccines Product Portfolios and Specifications
Table 139. CVCRI Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 140. CVCRI Main Business
Table 141. CVCRI Latest Developments
Table 142. IVPM Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. IVPM Anthrax Vaccines Product Portfolios and Specifications
Table 144. IVPM Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 145. IVPM Main Business
Table 146. IVPM Latest Developments
Table 147. Prondil Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Prondil Anthrax Vaccines Product Portfolios and Specifications
Table 149. Prondil Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 150. Prondil Main Business
Table 151. Prondil Latest Developments
Table 152. CDV Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. CDV Anthrax Vaccines Product Portfolios and Specifications
Table 154. CDV Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 155. CDV Main Business
Table 156. CDV Latest Developments
Table 157. Indian Immunologicals Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. Indian Immunologicals Anthrax Vaccines Product Portfolios and Specifications
Table 159. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 160. Indian Immunologicals Main Business
Table 161. Indian Immunologicals Latest Developments
Table 162. Botswana Vaccine Institute Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 163. Botswana Vaccine Institute Anthrax Vaccines Product Portfolios and Specifications
Table 164. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 165. Botswana Vaccine Institute Main Business
Table 166. Botswana Vaccine Institute Latest Developments
Table 167. Ceva Santй Animale Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 168. Ceva Santй Animale Anthrax Vaccines Product Portfolios and Specifications
Table 169. Ceva Santй Animale Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 170. Ceva Santй Animale Main Business
Table 171. Ceva Santй Animale Latest Developments
Table 172. Intervac Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 173. Intervac Anthrax Vaccines Product Portfolios and Specifications
Table 174. Intervac Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 175. Intervac Main Business
Table 176. Intervac Latest Developments
Table 177. JOVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 178. JOVAC Anthrax Vaccines Product Portfolios and Specifications
Table 179. JOVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 180. JOVAC Main Business
Table 181. JOVAC Latest Developments
LIST OFFIGURES
Figure 1. Picture of Anthrax Vaccines
Figure 2. Anthrax Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anthrax Vaccines Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Anthrax Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anthrax Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anthrax Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Anthrax Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Live Vaccines
Figure 12. Product Picture of Cell free PA Vaccines
Figure 13. Global Anthrax Vaccines Sales Market Share byType in 2025
Figure 14. Global Anthrax Vaccines Revenue Market Share byType (2020-2025)
Figure 15. Anthrax Vaccines Consumed in Human Use
Figure 16. Global Anthrax Vaccines Market: Human Use (2020-2025) & (M Doses)
Figure 17. Anthrax Vaccines Consumed in Animal Use
Figure 18. Global Anthrax Vaccines Market: Animal Use (2020-2025) & (M Doses)
Figure 19. Global Anthrax Vaccines Sale Market Share by Application (2024)
Figure 20. Global Anthrax Vaccines Revenue Market Share by Application in 2025
Figure 21. Anthrax Vaccines Sales by Company in 2025 (M Doses)
Figure 22. Global Anthrax Vaccines Sales Market Share by Company in 2025
Figure 23. Anthrax Vaccines Revenue by Company in 2025 ($ millions)
Figure 24. Global Anthrax Vaccines Revenue Market Share by Company in 2025
Figure 25. Global Anthrax Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Anthrax Vaccines Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Anthrax Vaccines Sales 2020-2025 (M Doses)
Figure 28. Americas Anthrax Vaccines Revenue 2020-2025 ($ millions)
Figure 29. APAC Anthrax Vaccines Sales 2020-2025 (M Doses)
Figure 30. APAC Anthrax Vaccines Revenue 2020-2025 ($ millions)
Figure 31. Europe Anthrax Vaccines Sales 2020-2025 (M Doses)
Figure 32. Europe Anthrax Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Anthrax Vaccines Sales 2020-2025 (M Doses)
Figure 34. Middle East & Africa Anthrax Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Americas Anthrax Vaccines Sales Market Share by Country in 2025
Figure 36. Americas Anthrax Vaccines Revenue Market Share by Country (2020-2025)
Figure 37. Americas Anthrax Vaccines Sales Market Share byType (2020-2025)
Figure 38. Americas Anthrax Vaccines Sales Market Share by Application (2020-2025)
Figure 39. United States Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Anthrax Vaccines Sales Market Share by Region in 2025
Figure 44. APAC Anthrax Vaccines Revenue Market Share by Region (2020-2025)
Figure 45. APAC Anthrax Vaccines Sales Market Share byType (2020-2025)
Figure 46. APAC Anthrax Vaccines Sales Market Share by Application (2020-2025)
Figure 47. China Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. India Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Anthrax Vaccines Sales Market Share by Country in 2025
Figure 55. Europe Anthrax Vaccines Revenue Market Share by Country (2020-2025)
Figure 56. Europe Anthrax Vaccines Sales Market Share byType (2020-2025)
Figure 57. Europe Anthrax Vaccines Sales Market Share by Application (2020-2025)
Figure 58. Germany Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59.France Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Anthrax Vaccines Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Anthrax Vaccines Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Anthrax Vaccines Sales Market Share by Application (2020-2025)
Figure 66. Egypt Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Anthrax Vaccines in 2025
Figure 72. Manufacturing Process Analysis of Anthrax Vaccines
Figure 73. Industry Chain Structure of Anthrax Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Anthrax Vaccines Sales MarketForecast by Region (2026-2031)
Figure 76. Global Anthrax Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Anthrax Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Anthrax Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Anthrax Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Anthrax Vaccines Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anthrax Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anthrax Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anthrax Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Anthrax Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell free PA Vaccines
2.3 Anthrax Vaccines Sales by Type
2.3.1 Global Anthrax Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Anthrax Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anthrax Vaccines Sale Price by Type (2020-2025)
2.4 Anthrax Vaccines Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Anthrax Vaccines Sales by Application
2.5.1 Global Anthrax Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Anthrax Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anthrax Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anthrax Vaccines Breakdown Data by Company
3.1.1 Global Anthrax Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Anthrax Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Anthrax Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Anthrax Vaccines Revenue by Company (2020-2025)
3.2.2 Global Anthrax Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Anthrax Vaccines Sale Price by Company
3.4 Key Manufacturers Anthrax Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anthrax Vaccines Product Location Distribution
3.4.2 Players Anthrax Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTHRAX VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Anthrax Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Anthrax Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anthrax Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anthrax Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Anthrax Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anthrax Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anthrax Vaccines Sales Growth
4.4 APAC Anthrax Vaccines Sales Growth
4.5 Europe Anthrax Vaccines Sales Growth
4.6 Middle East & Africa Anthrax Vaccines Sales Growth
5 AMERICAS
5.1 Americas Anthrax Vaccines Sales by Country
5.1.1 Americas Anthrax Vaccines Sales by Country (2020-2025)
5.1.2 Americas Anthrax Vaccines Revenue by Country (2020-2025)
5.2 Americas Anthrax Vaccines Sales by Type (2020-2025)
5.3 Americas Anthrax Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anthrax Vaccines Sales by Region
6.1.1 APAC Anthrax Vaccines Sales by Region (2020-2025)
6.1.2 APAC Anthrax Vaccines Revenue by Region (2020-2025)
6.2 APAC Anthrax Vaccines Sales by Type (2020-2025)
6.3 APAC Anthrax Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anthrax Vaccines by Country
7.1.1 Europe Anthrax Vaccines Sales by Country (2020-2025)
7.1.2 Europe Anthrax Vaccines Revenue by Country (2020-2025)
7.2 Europe Anthrax Vaccines Sales by Type (2020-2025)
7.3 Europe Anthrax Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anthrax Vaccines by Country
8.1.1 Middle East & Africa Anthrax Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anthrax Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Anthrax Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Anthrax Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anthrax Vaccines
10.3 Manufacturing Process Analysis of Anthrax Vaccines
10.4 Industry Chain Structure of Anthrax Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anthrax Vaccines Distributors
11.3 Anthrax Vaccines Customer
12 WORLD FORECAST REVIEW FOR ANTHRAX VACCINES BY GEOGRAPHIC REGION
12.1 Global Anthrax Vaccines Market Size Forecast by Region
12.1.1 Global Anthrax Vaccines Forecast by Region (2026-2031)
12.1.2 Global Anthrax Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anthrax Vaccines Forecast by Type (2026-2031)
12.7 Global Anthrax Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Emergent BioSolutions
13.1.1 Emergent BioSolutions Company Information
13.1.2 Emergent BioSolutions Anthrax Vaccines Product Portfolios and Specifications
13.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Emergent BioSolutions Main Business Overview
13.1.5 Emergent BioSolutions Latest Developments
13.2 Merial
13.2.1 Merial Company Information
13.2.2 Merial Anthrax Vaccines Product Portfolios and Specifications
13.2.3 Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merial Main Business Overview
13.2.5 Merial Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Anthrax Vaccines Product Portfolios and Specifications
13.3.3 Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Zoetis
13.4.1 Zoetis Company Information
13.4.2 Zoetis Anthrax Vaccines Product Portfolios and Specifications
13.4.3 Zoetis Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Zoetis Main Business Overview
13.4.5 Zoetis Latest Developments
13.5 Bayer Sanidad Animal
13.5.1 Bayer Sanidad Animal Company Information
13.5.2 Bayer Sanidad Animal Anthrax Vaccines Product Portfolios and Specifications
13.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bayer Sanidad Animal Main Business Overview
13.5.5 Bayer Sanidad Animal Latest Developments
13.6 Colorado Serum
13.6.1 Colorado Serum Company Information
13.6.2 Colorado Serum Anthrax Vaccines Product Portfolios and Specifications
13.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Colorado Serum Main Business Overview
13.6.5 Colorado Serum Latest Developments
13.7 PharmAthene
13.7.1 PharmAthene Company Information
13.7.2 PharmAthene Anthrax Vaccines Product Portfolios and Specifications
13.7.3 PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 PharmAthene Main Business Overview
13.7.5 PharmAthene Latest Developments
13.8 Tiankang
13.8.1 Tiankang Company Information
13.8.2 Tiankang Anthrax Vaccines Product Portfolios and Specifications
13.8.3 Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Tiankang Main Business Overview
13.8.5 Tiankang Latest Developments
13.9 Biogйnesis-Bago
13.9.1 Biogйnesis-Bago Company Information
13.9.2 Biogйnesis-Bago Anthrax Vaccines Product Portfolios and Specifications
13.9.3 Biogйnesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Biogйnesis-Bago Main Business Overview
13.9.5 Biogйnesis-Bago Latest Developments
13.10 CAVAC
13.10.1 CAVAC Company Information
13.10.2 CAVAC Anthrax Vaccines Product Portfolios and Specifications
13.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 CAVAC Main Business Overview
13.10.5 CAVAC Latest Developments
13.11 Rosenbusch
13.11.1 Rosenbusch Company Information
13.11.2 Rosenbusch Anthrax Vaccines Product Portfolios and Specifications
13.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Rosenbusch Main Business Overview
13.11.5 Rosenbusch Latest Developments
13.12 Agrovet
13.12.1 Agrovet Company Information
13.12.2 Agrovet Anthrax Vaccines Product Portfolios and Specifications
13.12.3 Agrovet Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Agrovet Main Business Overview
13.12.5 Agrovet Latest Developments
13.13 Vecol
13.13.1 Vecol Company Information
13.13.2 Vecol Anthrax Vaccines Product Portfolios and Specifications
13.13.3 Vecol Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Vecol Main Business Overview
13.13.5 Vecol Latest Developments
13.14 CVCRI
13.14.1 CVCRI Company Information
13.14.2 CVCRI Anthrax Vaccines Product Portfolios and Specifications
13.14.3 CVCRI Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 CVCRI Main Business Overview
13.14.5 CVCRI Latest Developments
13.15 IVPM
13.15.1 IVPM Company Information
13.15.2 IVPM Anthrax Vaccines Product Portfolios and Specifications
13.15.3 IVPM Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 IVPM Main Business Overview
13.15.5 IVPM Latest Developments
13.16 Prondil
13.16.1 Prondil Company Information
13.16.2 Prondil Anthrax Vaccines Product Portfolios and Specifications
13.16.3 Prondil Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Prondil Main Business Overview
13.16.5 Prondil Latest Developments
13.17 CDV
13.17.1 CDV Company Information
13.17.2 CDV Anthrax Vaccines Product Portfolios and Specifications
13.17.3 CDV Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 CDV Main Business Overview
13.17.5 CDV Latest Developments
13.18 Indian Immunologicals
13.18.1 Indian Immunologicals Company Information
13.18.2 Indian Immunologicals Anthrax Vaccines Product Portfolios and Specifications
13.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Indian Immunologicals Main Business Overview
13.18.5 Indian Immunologicals Latest Developments
13.19 Botswana Vaccine Institute
13.19.1 Botswana Vaccine Institute Company Information
13.19.2 Botswana Vaccine Institute Anthrax Vaccines Product Portfolios and Specifications
13.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Botswana Vaccine Institute Main Business Overview
13.19.5 Botswana Vaccine Institute Latest Developments
13.20 Ceva Santй Animale
13.20.1 Ceva Santй Animale Company Information
13.20.2 Ceva Santй Animale Anthrax Vaccines Product Portfolios and Specifications
13.20.3 Ceva Santй Animale Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Ceva Santй Animale Main Business Overview
13.20.5 Ceva Santй Animale Latest Developments
13.21 Intervac
13.21.1 Intervac Company Information
13.21.2 Intervac Anthrax Vaccines Product Portfolios and Specifications
13.21.3 Intervac Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Intervac Main Business Overview
13.21.5 Intervac Latest Developments
13.22 JOVAC
13.22.1 JOVAC Company Information
13.22.2 JOVAC Anthrax Vaccines Product Portfolios and Specifications
13.22.3 JOVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 JOVAC Main Business Overview
13.22.5 JOVAC Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Anthrax Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anthrax Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Cell free PA Vaccines
Table 5. Global Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 6. Global Anthrax Vaccines Sales Market Share byType (2020-2025)
Table 7. Global Anthrax Vaccines Revenue byType (2020-2025) & ($ million)
Table 8. Global Anthrax Vaccines Revenue Market Share byType (2020-2025)
Table 9. Global Anthrax Vaccines Sale Price byType (2020-2025) & (USD/Dose)
Table 10. Global Anthrax Vaccines Sale by Application (2020-2025) & (M Doses)
Table 11. Global Anthrax Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Anthrax Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Anthrax Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Anthrax Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Anthrax Vaccines Sales by Company (2020-2025) & (M Doses)
Table 16. Global Anthrax Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Anthrax Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Anthrax Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Anthrax Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Anthrax Vaccines Producing Area Distribution and Sales Area
Table 21. Players Anthrax Vaccines Products Offered
Table 22. Anthrax Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Anthrax Vaccines Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Anthrax Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Anthrax Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Anthrax Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Anthrax Vaccines Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Anthrax Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Anthrax Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Anthrax Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Anthrax Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Anthrax Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 37. Americas Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Anthrax Vaccines Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Anthrax Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Anthrax Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 42. APAC Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Anthrax Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 46. Europe Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Anthrax Vaccines Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Anthrax Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Anthrax Vaccines Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa Anthrax Vaccines Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Anthrax Vaccines
Table 52. Key Market Challenges & Risks of Anthrax Vaccines
Table 53. Key IndustryTrends of Anthrax Vaccines
Table 54. Anthrax Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Anthrax Vaccines Distributors List
Table 57. Anthrax Vaccines Customer List
Table 58. Global Anthrax Vaccines SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global Anthrax Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Anthrax Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas Anthrax Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Anthrax Vaccines SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC Anthrax Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Anthrax Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe Anthrax Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Anthrax Vaccines SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Anthrax Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Anthrax Vaccines SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global Anthrax Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Anthrax Vaccines SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global Anthrax Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Emergent BioSolutions Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Emergent BioSolutions Anthrax Vaccines Product Portfolios and Specifications
Table 74. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Emergent BioSolutions Main Business
Table 76. Emergent BioSolutions Latest Developments
Table 77. Merial Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Merial Anthrax Vaccines Product Portfolios and Specifications
Table 79. Merial Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Merial Main Business
Table 81. Merial Latest Developments
Table 82. Merck Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Anthrax Vaccines Product Portfolios and Specifications
Table 84. Merck Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Zoetis Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Zoetis Anthrax Vaccines Product Portfolios and Specifications
Table 89. Zoetis Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Zoetis Main Business
Table 91. Zoetis Latest Developments
Table 92. Bayer Sanidad Animal Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer Sanidad Animal Anthrax Vaccines Product Portfolios and Specifications
Table 94. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Bayer Sanidad Animal Main Business
Table 96. Bayer Sanidad Animal Latest Developments
Table 97. Colorado Serum Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Colorado Serum Anthrax Vaccines Product Portfolios and Specifications
Table 99. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Colorado Serum Main Business
Table 101. Colorado Serum Latest Developments
Table 102. PharmAthene Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. PharmAthene Anthrax Vaccines Product Portfolios and Specifications
Table 104. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. PharmAthene Main Business
Table 106. PharmAthene Latest Developments
Table 107.Tiankang Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108.Tiankang Anthrax Vaccines Product Portfolios and Specifications
Table 109.Tiankang Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110.Tiankang Main Business
Table 111.Tiankang Latest Developments
Table 112. Biogйnesis-Bago Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Biogйnesis-Bago Anthrax Vaccines Product Portfolios and Specifications
Table 114. Biogйnesis-Bago Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 115. Biogйnesis-Bago Main Business
Table 116. Biogйnesis-Bago Latest Developments
Table 117. CAVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. CAVAC Anthrax Vaccines Product Portfolios and Specifications
Table 119. CAVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 120. CAVAC Main Business
Table 121. CAVAC Latest Developments
Table 122. Rosenbusch Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Rosenbusch Anthrax Vaccines Product Portfolios and Specifications
Table 124. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 125. Rosenbusch Main Business
Table 126. Rosenbusch Latest Developments
Table 127. Agrovet Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Agrovet Anthrax Vaccines Product Portfolios and Specifications
Table 129. Agrovet Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 130. Agrovet Main Business
Table 131. Agrovet Latest Developments
Table 132. Vecol Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Vecol Anthrax Vaccines Product Portfolios and Specifications
Table 134. Vecol Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 135. Vecol Main Business
Table 136. Vecol Latest Developments
Table 137. CVCRI Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. CVCRI Anthrax Vaccines Product Portfolios and Specifications
Table 139. CVCRI Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 140. CVCRI Main Business
Table 141. CVCRI Latest Developments
Table 142. IVPM Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. IVPM Anthrax Vaccines Product Portfolios and Specifications
Table 144. IVPM Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 145. IVPM Main Business
Table 146. IVPM Latest Developments
Table 147. Prondil Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Prondil Anthrax Vaccines Product Portfolios and Specifications
Table 149. Prondil Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 150. Prondil Main Business
Table 151. Prondil Latest Developments
Table 152. CDV Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. CDV Anthrax Vaccines Product Portfolios and Specifications
Table 154. CDV Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 155. CDV Main Business
Table 156. CDV Latest Developments
Table 157. Indian Immunologicals Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. Indian Immunologicals Anthrax Vaccines Product Portfolios and Specifications
Table 159. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 160. Indian Immunologicals Main Business
Table 161. Indian Immunologicals Latest Developments
Table 162. Botswana Vaccine Institute Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 163. Botswana Vaccine Institute Anthrax Vaccines Product Portfolios and Specifications
Table 164. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 165. Botswana Vaccine Institute Main Business
Table 166. Botswana Vaccine Institute Latest Developments
Table 167. Ceva Santй Animale Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 168. Ceva Santй Animale Anthrax Vaccines Product Portfolios and Specifications
Table 169. Ceva Santй Animale Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 170. Ceva Santй Animale Main Business
Table 171. Ceva Santй Animale Latest Developments
Table 172. Intervac Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 173. Intervac Anthrax Vaccines Product Portfolios and Specifications
Table 174. Intervac Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 175. Intervac Main Business
Table 176. Intervac Latest Developments
Table 177. JOVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 178. JOVAC Anthrax Vaccines Product Portfolios and Specifications
Table 179. JOVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 180. JOVAC Main Business
Table 181. JOVAC Latest Developments
LIST OFFIGURES
Figure 1. Picture of Anthrax Vaccines
Figure 2. Anthrax Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anthrax Vaccines Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Anthrax Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anthrax Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anthrax Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Anthrax Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Live Vaccines
Figure 12. Product Picture of Cell free PA Vaccines
Figure 13. Global Anthrax Vaccines Sales Market Share byType in 2025
Figure 14. Global Anthrax Vaccines Revenue Market Share byType (2020-2025)
Figure 15. Anthrax Vaccines Consumed in Human Use
Figure 16. Global Anthrax Vaccines Market: Human Use (2020-2025) & (M Doses)
Figure 17. Anthrax Vaccines Consumed in Animal Use
Figure 18. Global Anthrax Vaccines Market: Animal Use (2020-2025) & (M Doses)
Figure 19. Global Anthrax Vaccines Sale Market Share by Application (2024)
Figure 20. Global Anthrax Vaccines Revenue Market Share by Application in 2025
Figure 21. Anthrax Vaccines Sales by Company in 2025 (M Doses)
Figure 22. Global Anthrax Vaccines Sales Market Share by Company in 2025
Figure 23. Anthrax Vaccines Revenue by Company in 2025 ($ millions)
Figure 24. Global Anthrax Vaccines Revenue Market Share by Company in 2025
Figure 25. Global Anthrax Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Anthrax Vaccines Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Anthrax Vaccines Sales 2020-2025 (M Doses)
Figure 28. Americas Anthrax Vaccines Revenue 2020-2025 ($ millions)
Figure 29. APAC Anthrax Vaccines Sales 2020-2025 (M Doses)
Figure 30. APAC Anthrax Vaccines Revenue 2020-2025 ($ millions)
Figure 31. Europe Anthrax Vaccines Sales 2020-2025 (M Doses)
Figure 32. Europe Anthrax Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Anthrax Vaccines Sales 2020-2025 (M Doses)
Figure 34. Middle East & Africa Anthrax Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Americas Anthrax Vaccines Sales Market Share by Country in 2025
Figure 36. Americas Anthrax Vaccines Revenue Market Share by Country (2020-2025)
Figure 37. Americas Anthrax Vaccines Sales Market Share byType (2020-2025)
Figure 38. Americas Anthrax Vaccines Sales Market Share by Application (2020-2025)
Figure 39. United States Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Anthrax Vaccines Sales Market Share by Region in 2025
Figure 44. APAC Anthrax Vaccines Revenue Market Share by Region (2020-2025)
Figure 45. APAC Anthrax Vaccines Sales Market Share byType (2020-2025)
Figure 46. APAC Anthrax Vaccines Sales Market Share by Application (2020-2025)
Figure 47. China Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. India Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Anthrax Vaccines Sales Market Share by Country in 2025
Figure 55. Europe Anthrax Vaccines Revenue Market Share by Country (2020-2025)
Figure 56. Europe Anthrax Vaccines Sales Market Share byType (2020-2025)
Figure 57. Europe Anthrax Vaccines Sales Market Share by Application (2020-2025)
Figure 58. Germany Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59.France Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Anthrax Vaccines Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Anthrax Vaccines Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Anthrax Vaccines Sales Market Share by Application (2020-2025)
Figure 66. Egypt Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Anthrax Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Anthrax Vaccines in 2025
Figure 72. Manufacturing Process Analysis of Anthrax Vaccines
Figure 73. Industry Chain Structure of Anthrax Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Anthrax Vaccines Sales MarketForecast by Region (2026-2031)
Figure 76. Global Anthrax Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Anthrax Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Anthrax Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Anthrax Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Anthrax Vaccines Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Anthrax Vaccines Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 3,480.00
May 2017
117 pages
